In partnership with our client LumiThera, Product Creation Studio’s work was recently named as a finalist for the 2019 Medical Design & Excellence Awards (MDEAs) in the Radiological, Imaging, and Electromechanical Devices category for the design of the LumiThera Valeda™ Light Delivery System.

The Valeda™ Light Delivery System is used in the treatment of dry age-related macular degeneration (AMD). The system consists of a series of light-based treatments to the retinal cells, resulting in improved energy production and addressing inflammation, ischemia, and metabolic dysfunction that contribute to the disease.

The annual Medical Design Excellence Awards (MDEA) is the premier awards program for the medtech industry that seeks to recognize the technological achievements of medical device manufacturers. Since its inception in 1998, the mission of the MDEAs has been to recognize significant achievements in medical product design and engineering that improve the quality of healthcare delivery and accessibility.

"We believe that it is important to recognize those who are improving the lives of others through their innovative work through the MDEA's," said Jamie Hartford, editor-in-chief of MD+DI and director of content for Medtech Brands in UBM's Advanced Manufacturing Group. 

The MDEA ceremony is produced by the Medical Device and Diagnostic Industry (MD+DI), takes place next month, June 11, at the Jacob K. Javits Convention Center in New York, NY.

About LumiThera

LumiThera is a commercial-stage medical device company focused on treating people affected by ocular disorders and diseases including dry age-related macular degeneration, a leading cause of blindness in adults over 65. The company is a leader in the use of PBM for the treatment of acute and chronic ocular diseases and disorders. The company is developing the office-based Valeda Light Delivery System to be used by eye care specialists as medical treatments.

The Valeda Light Delivery System is authorized to use the CE Mark by an EU Notified Body as required for commercial use in the European Union only. Valeda is not approved for use by the Food & Drug Administration (FDA) in the USA.

About the Medical Design & Excellence Awards (MDEAs)

The Medical Design Excellence Awards (MDEA), recognizing the technological achievements of medical device manufacturers, announced the 2019 finalists on May 1. Produced by the Medical Device and Diagnostic Industry (MD+DI), the MDEAs have recognized innovation in medical product design and engineering. Awards are granted across nine categories, announcing gold, silver and bronze medal winners in each category, in addition to naming the best in show and revealing the 2019 readers' choice winner. The MDEA ceremony is held in conjunction with Medical Design & Manufacturing (MD&M) East, which is taking place June 11 at the Jacob K. Javits Convention Center in New York, NY. To learn more about the MDEAs, please visit: mdeawards.mddionline.com.